Yoosakul, E., Seeduang, C., Chuasuwan, B., Manamuti, C., Pitisuttithum, P., Karachot, B., & Techatanawat, I. (2017). Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovel® 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasti. Journal of Health Research, 30(3), 199–205. Retrieved from https://he01.tci-thaijo.org/index.php/jhealthres/article/view/77939